nodes	percent_of_prediction	percent_of_DWPC	metapath
Halofantrine—CYP3A4—type 2 diabetes mellitus	0.229	1	CbGaD
Halofantrine—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0544	0.0983	CbGbCtD
Halofantrine—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0435	0.0786	CbGbCtD
Halofantrine—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0393	0.071	CbGbCtD
Halofantrine—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0363	0.0656	CbGbCtD
Halofantrine—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0351	0.0633	CbGbCtD
Halofantrine—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.031	0.056	CbGbCtD
Halofantrine—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0286	0.0516	CbGbCtD
Halofantrine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0251	0.0453	CbGbCtD
Halofantrine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0248	0.0447	CbGbCtD
Halofantrine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0232	0.0418	CbGbCtD
Halofantrine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0221	0.0399	CbGbCtD
Halofantrine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0202	0.0365	CbGbCtD
Halofantrine—CYP3A5—Losartan—type 2 diabetes mellitus	0.0192	0.0346	CbGbCtD
Halofantrine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.019	0.0343	CbGbCtD
Halofantrine—CYP2C8—Losartan—type 2 diabetes mellitus	0.0184	0.0333	CbGbCtD
Halofantrine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0182	0.0329	CbGbCtD
Halofantrine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0176	0.0319	CbGbCtD
Halofantrine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.016	0.0288	CbGbCtD
Halofantrine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0121	0.0218	CbGbCtD
Halofantrine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0116	0.0209	CbGbCtD
Halofantrine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0116	0.0209	CbGbCtD
Halofantrine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.011	0.0198	CbGbCtD
Halofantrine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00817	0.0148	CbGbCtD
Halofantrine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00747	0.0135	CbGbCtD
Halofantrine—Lumefantrine—CYP3A4—type 2 diabetes mellitus	0.00246	1	CrCbGaD
Halofantrine—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000262	0.00151	CcSEcCtD
Halofantrine—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000261	0.00151	CcSEcCtD
Halofantrine—Malaise—Orlistat—type 2 diabetes mellitus	0.000261	0.0015	CcSEcCtD
Halofantrine—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.00026	0.0015	CcSEcCtD
Halofantrine—Chills—Irbesartan—type 2 diabetes mellitus	0.000259	0.0015	CcSEcCtD
Halofantrine—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000259	0.00149	CcSEcCtD
Halofantrine—Palpitations—Valsartan—type 2 diabetes mellitus	0.000259	0.00149	CcSEcCtD
Halofantrine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000259	0.00149	CcSEcCtD
Halofantrine—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000258	0.00149	CcSEcCtD
Halofantrine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000257	0.00149	CcSEcCtD
Halofantrine—Palpitations—Orlistat—type 2 diabetes mellitus	0.000256	0.00147	CcSEcCtD
Halofantrine—Cough—Valsartan—type 2 diabetes mellitus	0.000255	0.00147	CcSEcCtD
Halofantrine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000255	0.00147	CcSEcCtD
Halofantrine—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000255	0.00147	CcSEcCtD
Halofantrine—Tinnitus—Losartan—type 2 diabetes mellitus	0.000253	0.00146	CcSEcCtD
Halofantrine—Stomatitis—Ramipril—type 2 diabetes mellitus	0.000253	0.00146	CcSEcCtD
Halofantrine—Cough—Orlistat—type 2 diabetes mellitus	0.000252	0.00146	CcSEcCtD
Halofantrine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000252	0.00145	CcSEcCtD
Halofantrine—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000252	0.00145	CcSEcCtD
Halofantrine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000252	0.00145	CcSEcCtD
Halofantrine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000251	0.00145	CcSEcCtD
Halofantrine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000251	0.00145	CcSEcCtD
Halofantrine—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.00025	0.00144	CcSEcCtD
Halofantrine—Chest pain—Valsartan—type 2 diabetes mellitus	0.000249	0.00144	CcSEcCtD
Halofantrine—Myalgia—Valsartan—type 2 diabetes mellitus	0.000249	0.00144	CcSEcCtD
Halofantrine—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000249	0.00144	CcSEcCtD
Halofantrine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000249	0.00144	CcSEcCtD
Halofantrine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000248	0.00143	CcSEcCtD
Halofantrine—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000247	0.00143	CcSEcCtD
Halofantrine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000247	0.00142	CcSEcCtD
Halofantrine—Chest pain—Orlistat—type 2 diabetes mellitus	0.000246	0.00142	CcSEcCtD
Halofantrine—Myalgia—Orlistat—type 2 diabetes mellitus	0.000246	0.00142	CcSEcCtD
Halofantrine—Discomfort—Orlistat—type 2 diabetes mellitus	0.000243	0.0014	CcSEcCtD
Halofantrine—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000243	0.0014	CcSEcCtD
Halofantrine—Malaise—Metformin—type 2 diabetes mellitus	0.00024	0.00139	CcSEcCtD
Halofantrine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00024	0.00139	CcSEcCtD
Halofantrine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000239	0.00138	CcSEcCtD
Halofantrine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000239	0.00138	CcSEcCtD
Halofantrine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000239	0.00138	CcSEcCtD
Halofantrine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000239	0.00138	CcSEcCtD
Halofantrine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000238	0.00138	CcSEcCtD
Halofantrine—Rash—Glipizide—type 2 diabetes mellitus	0.000237	0.00137	CcSEcCtD
Halofantrine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000237	0.00137	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000237	0.00137	CcSEcCtD
Halofantrine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000237	0.00137	CcSEcCtD
Halofantrine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000236	0.00136	CcSEcCtD
Halofantrine—Headache—Glipizide—type 2 diabetes mellitus	0.000236	0.00136	CcSEcCtD
Halofantrine—Palpitations—Metformin—type 2 diabetes mellitus	0.000235	0.00136	CcSEcCtD
Halofantrine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000233	0.00135	CcSEcCtD
Halofantrine—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000233	0.00135	CcSEcCtD
Halofantrine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000232	0.00134	CcSEcCtD
Halofantrine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000231	0.00134	CcSEcCtD
Halofantrine—Urticaria—Glyburide—type 2 diabetes mellitus	0.00023	0.00133	CcSEcCtD
Halofantrine—Back pain—Losartan—type 2 diabetes mellitus	0.000229	0.00132	CcSEcCtD
Halofantrine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000229	0.00132	CcSEcCtD
Halofantrine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000229	0.00132	CcSEcCtD
Halofantrine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000228	0.00131	CcSEcCtD
Halofantrine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000227	0.00131	CcSEcCtD
Halofantrine—Chest pain—Metformin—type 2 diabetes mellitus	0.000227	0.00131	CcSEcCtD
Halofantrine—Myalgia—Metformin—type 2 diabetes mellitus	0.000227	0.00131	CcSEcCtD
Halofantrine—Malaise—Irbesartan—type 2 diabetes mellitus	0.000227	0.00131	CcSEcCtD
Halofantrine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000226	0.0013	CcSEcCtD
Halofantrine—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000225	0.0013	CcSEcCtD
Halofantrine—Discomfort—Metformin—type 2 diabetes mellitus	0.000224	0.00129	CcSEcCtD
Halofantrine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000224	0.00129	CcSEcCtD
Halofantrine—Nausea—Glipizide—type 2 diabetes mellitus	0.000223	0.00129	CcSEcCtD
Halofantrine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000223	0.00129	CcSEcCtD
Halofantrine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000222	0.00128	CcSEcCtD
Halofantrine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000222	0.00128	CcSEcCtD
Halofantrine—Rash—Glimepiride—type 2 diabetes mellitus	0.000221	0.00128	CcSEcCtD
Halofantrine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000221	0.00128	CcSEcCtD
Halofantrine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000221	0.00127	CcSEcCtD
Halofantrine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00022	0.00127	CcSEcCtD
Halofantrine—Headache—Glimepiride—type 2 diabetes mellitus	0.00022	0.00127	CcSEcCtD
Halofantrine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.00022	0.00127	CcSEcCtD
Halofantrine—Cough—Irbesartan—type 2 diabetes mellitus	0.000219	0.00127	CcSEcCtD
Halofantrine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000219	0.00127	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000218	0.00126	CcSEcCtD
Halofantrine—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000217	0.00125	CcSEcCtD
Halofantrine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000217	0.00125	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000215	0.00124	CcSEcCtD
Halofantrine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000214	0.00124	CcSEcCtD
Halofantrine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000214	0.00124	CcSEcCtD
Halofantrine—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000214	0.00124	CcSEcCtD
Halofantrine—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000214	0.00124	CcSEcCtD
Halofantrine—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000214	0.00124	CcSEcCtD
Halofantrine—Malaise—Losartan—type 2 diabetes mellitus	0.000213	0.00123	CcSEcCtD
Halofantrine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000213	0.00123	CcSEcCtD
Halofantrine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000212	0.00122	CcSEcCtD
Halofantrine—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000212	0.00122	CcSEcCtD
Halofantrine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.00021	0.00121	CcSEcCtD
Halofantrine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000209	0.00121	CcSEcCtD
Halofantrine—Palpitations—Losartan—type 2 diabetes mellitus	0.000209	0.00121	CcSEcCtD
Halofantrine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000208	0.0012	CcSEcCtD
Halofantrine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000208	0.0012	CcSEcCtD
Halofantrine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000208	0.0012	CcSEcCtD
Halofantrine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000208	0.0012	CcSEcCtD
Halofantrine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000208	0.0012	CcSEcCtD
Halofantrine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000208	0.0012	CcSEcCtD
Halofantrine—Anorexia—Metformin—type 2 diabetes mellitus	0.000207	0.0012	CcSEcCtD
Halofantrine—Cough—Losartan—type 2 diabetes mellitus	0.000207	0.00119	CcSEcCtD
Halofantrine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000206	0.00119	CcSEcCtD
Halofantrine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000206	0.00119	CcSEcCtD
Halofantrine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000205	0.00119	CcSEcCtD
Halofantrine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000205	0.00118	CcSEcCtD
Halofantrine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000205	0.00118	CcSEcCtD
Halofantrine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000205	0.00118	CcSEcCtD
Halofantrine—Constipation—Valsartan—type 2 diabetes mellitus	0.000204	0.00118	CcSEcCtD
Halofantrine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000203	0.00117	CcSEcCtD
Halofantrine—Chest pain—Losartan—type 2 diabetes mellitus	0.000201	0.00116	CcSEcCtD
Halofantrine—Arthralgia—Losartan—type 2 diabetes mellitus	0.000201	0.00116	CcSEcCtD
Halofantrine—Myalgia—Losartan—type 2 diabetes mellitus	0.000201	0.00116	CcSEcCtD
Halofantrine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000201	0.00116	CcSEcCtD
Halofantrine—Rash—Bromocriptine—type 2 diabetes mellitus	0.0002	0.00115	CcSEcCtD
Halofantrine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000199	0.00115	CcSEcCtD
Halofantrine—Discomfort—Losartan—type 2 diabetes mellitus	0.000199	0.00115	CcSEcCtD
Halofantrine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000198	0.00114	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000198	0.00114	CcSEcCtD
Halofantrine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000198	0.00114	CcSEcCtD
Halofantrine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000196	0.00113	CcSEcCtD
Halofantrine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000195	0.00113	CcSEcCtD
Halofantrine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000195	0.00113	CcSEcCtD
Halofantrine—Confusional state—Losartan—type 2 diabetes mellitus	0.000195	0.00112	CcSEcCtD
Halofantrine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000194	0.00112	CcSEcCtD
Halofantrine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000193	0.00111	CcSEcCtD
Halofantrine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000193	0.00111	CcSEcCtD
Halofantrine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000191	0.0011	CcSEcCtD
Halofantrine—Urticaria—Valsartan—type 2 diabetes mellitus	0.00019	0.00109	CcSEcCtD
Halofantrine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000189	0.00109	CcSEcCtD
Halofantrine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000189	0.00109	CcSEcCtD
Halofantrine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000188	0.00109	CcSEcCtD
Halofantrine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000188	0.00109	CcSEcCtD
Halofantrine—Fatigue—Metformin—type 2 diabetes mellitus	0.000187	0.00108	CcSEcCtD
Halofantrine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000187	0.00108	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000187	0.00108	CcSEcCtD
Halofantrine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000187	0.00108	CcSEcCtD
Halofantrine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000186	0.00108	CcSEcCtD
Halofantrine—Constipation—Metformin—type 2 diabetes mellitus	0.000186	0.00107	CcSEcCtD
Halofantrine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000184	0.00106	CcSEcCtD
Halofantrine—Anorexia—Losartan—type 2 diabetes mellitus	0.000184	0.00106	CcSEcCtD
Halofantrine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000184	0.00106	CcSEcCtD
Halofantrine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000184	0.00106	CcSEcCtD
Halofantrine—Malaise—Ramipril—type 2 diabetes mellitus	0.000183	0.00106	CcSEcCtD
Halofantrine—Rash—Glyburide—type 2 diabetes mellitus	0.000183	0.00105	CcSEcCtD
Halofantrine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000182	0.00105	CcSEcCtD
Halofantrine—Headache—Glyburide—type 2 diabetes mellitus	0.000181	0.00105	CcSEcCtD
Halofantrine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000181	0.00104	CcSEcCtD
Halofantrine—Palpitations—Ramipril—type 2 diabetes mellitus	0.000179	0.00103	CcSEcCtD
Halofantrine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000179	0.00103	CcSEcCtD
Halofantrine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000178	0.00103	CcSEcCtD
Halofantrine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000178	0.00103	CcSEcCtD
Halofantrine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000178	0.00103	CcSEcCtD
Halofantrine—Cough—Ramipril—type 2 diabetes mellitus	0.000177	0.00102	CcSEcCtD
Halofantrine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000177	0.00102	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000176	0.00102	CcSEcCtD
Halofantrine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000176	0.00101	CcSEcCtD
Halofantrine—Constipation—Irbesartan—type 2 diabetes mellitus	0.000176	0.00101	CcSEcCtD
Halofantrine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000173	0.001	CcSEcCtD
Halofantrine—Urticaria—Metformin—type 2 diabetes mellitus	0.000173	0.000997	CcSEcCtD
Halofantrine—Chest pain—Ramipril—type 2 diabetes mellitus	0.000173	0.000997	CcSEcCtD
Halofantrine—Myalgia—Ramipril—type 2 diabetes mellitus	0.000173	0.000997	CcSEcCtD
Halofantrine—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000173	0.000997	CcSEcCtD
Halofantrine—Nausea—Glyburide—type 2 diabetes mellitus	0.000172	0.000992	CcSEcCtD
Halofantrine—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000172	0.000992	CcSEcCtD
Halofantrine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000172	0.000992	CcSEcCtD
Halofantrine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000171	0.000989	CcSEcCtD
Halofantrine—Discomfort—Ramipril—type 2 diabetes mellitus	0.000171	0.000985	CcSEcCtD
Halofantrine—Dyspepsia—Losartan—type 2 diabetes mellitus	0.00017	0.000981	CcSEcCtD
Halofantrine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000169	0.000977	CcSEcCtD
Halofantrine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000169	0.000976	CcSEcCtD
Halofantrine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000169	0.000975	CcSEcCtD
Halofantrine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000168	0.000969	CcSEcCtD
Halofantrine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000168	0.000969	CcSEcCtD
Halofantrine—Confusional state—Ramipril—type 2 diabetes mellitus	0.000167	0.000964	CcSEcCtD
Halofantrine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000167	0.000964	CcSEcCtD
Halofantrine—Fatigue—Losartan—type 2 diabetes mellitus	0.000167	0.000961	CcSEcCtD
Halofantrine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000166	0.000956	CcSEcCtD
Halofantrine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000165	0.000954	CcSEcCtD
Halofantrine—Constipation—Losartan—type 2 diabetes mellitus	0.000165	0.000953	CcSEcCtD
Halofantrine—Rash—Gliclazide—type 2 diabetes mellitus	0.000164	0.000946	CcSEcCtD
Halofantrine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000164	0.000945	CcSEcCtD
Halofantrine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000163	0.000943	CcSEcCtD
Halofantrine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000163	0.000941	CcSEcCtD
Halofantrine—Headache—Gliclazide—type 2 diabetes mellitus	0.000163	0.00094	CcSEcCtD
Halofantrine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000162	0.000936	CcSEcCtD
Halofantrine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000161	0.000932	CcSEcCtD
Halofantrine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000159	0.000919	CcSEcCtD
Halofantrine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000158	0.000911	CcSEcCtD
Halofantrine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000158	0.000911	CcSEcCtD
Halofantrine—Anorexia—Ramipril—type 2 diabetes mellitus	0.000158	0.000911	CcSEcCtD
Halofantrine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000156	0.000901	CcSEcCtD
Halofantrine—Asthenia—Metformin—type 2 diabetes mellitus	0.000156	0.000901	CcSEcCtD
Halofantrine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000154	0.000891	CcSEcCtD
Halofantrine—Pruritus—Metformin—type 2 diabetes mellitus	0.000154	0.000888	CcSEcCtD
Halofantrine—Urticaria—Losartan—type 2 diabetes mellitus	0.000153	0.000886	CcSEcCtD
Halofantrine—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000153	0.000881	CcSEcCtD
Halofantrine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000152	0.000876	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000151	0.000871	CcSEcCtD
Halofantrine—Rash—Valsartan—type 2 diabetes mellitus	0.000151	0.000869	CcSEcCtD
Halofantrine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00015	0.000868	CcSEcCtD
Halofantrine—Vomiting—Orlistat—type 2 diabetes mellitus	0.00015	0.000866	CcSEcCtD
Halofantrine—Headache—Valsartan—type 2 diabetes mellitus	0.00015	0.000863	CcSEcCtD
Halofantrine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000149	0.000859	CcSEcCtD
Halofantrine—Rash—Orlistat—type 2 diabetes mellitus	0.000149	0.000859	CcSEcCtD
Halofantrine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000149	0.000858	CcSEcCtD
Halofantrine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000149	0.000858	CcSEcCtD
Halofantrine—Headache—Orlistat—type 2 diabetes mellitus	0.000148	0.000853	CcSEcCtD
Halofantrine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000147	0.00085	CcSEcCtD
Halofantrine—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000146	0.000841	CcSEcCtD
Halofantrine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000145	0.000838	CcSEcCtD
Halofantrine—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000144	0.000831	CcSEcCtD
Halofantrine—Dizziness—Metformin—type 2 diabetes mellitus	0.000144	0.00083	CcSEcCtD
Halofantrine—Fatigue—Ramipril—type 2 diabetes mellitus	0.000143	0.000824	CcSEcCtD
Halofantrine—Nausea—Valsartan—type 2 diabetes mellitus	0.000142	0.000819	CcSEcCtD
Halofantrine—Constipation—Ramipril—type 2 diabetes mellitus	0.000142	0.000817	CcSEcCtD
Halofantrine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00014	0.00081	CcSEcCtD
Halofantrine—Nausea—Orlistat—type 2 diabetes mellitus	0.00014	0.000809	CcSEcCtD
Halofantrine—Asthenia—Losartan—type 2 diabetes mellitus	0.000139	0.0008	CcSEcCtD
Halofantrine—Vomiting—Metformin—type 2 diabetes mellitus	0.000138	0.000798	CcSEcCtD
Halofantrine—Rash—Metformin—type 2 diabetes mellitus	0.000137	0.000791	CcSEcCtD
Halofantrine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000137	0.000791	CcSEcCtD
Halofantrine—Pruritus—Losartan—type 2 diabetes mellitus	0.000137	0.000789	CcSEcCtD
Halofantrine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000136	0.000788	CcSEcCtD
Halofantrine—Headache—Metformin—type 2 diabetes mellitus	0.000136	0.000786	CcSEcCtD
Halofantrine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000136	0.000783	CcSEcCtD
Halofantrine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000135	0.000782	CcSEcCtD
Halofantrine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000132	0.000763	CcSEcCtD
Halofantrine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000132	0.000759	CcSEcCtD
Halofantrine—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000131	0.000756	CcSEcCtD
Halofantrine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00013	0.000753	CcSEcCtD
Halofantrine—Rash—Irbesartan—type 2 diabetes mellitus	0.000129	0.000747	CcSEcCtD
Halofantrine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000129	0.000746	CcSEcCtD
Halofantrine—Nausea—Metformin—type 2 diabetes mellitus	0.000129	0.000746	CcSEcCtD
Halofantrine—Headache—Irbesartan—type 2 diabetes mellitus	0.000129	0.000742	CcSEcCtD
Halofantrine—Dizziness—Losartan—type 2 diabetes mellitus	0.000128	0.000737	CcSEcCtD
Halofantrine—Vomiting—Losartan—type 2 diabetes mellitus	0.000123	0.000709	CcSEcCtD
Halofantrine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000122	0.000704	CcSEcCtD
Halofantrine—Rash—Losartan—type 2 diabetes mellitus	0.000122	0.000703	CcSEcCtD
Halofantrine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000122	0.000702	CcSEcCtD
Halofantrine—Headache—Losartan—type 2 diabetes mellitus	0.000121	0.000698	CcSEcCtD
Halofantrine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000119	0.000686	CcSEcCtD
Halofantrine—Pruritus—Ramipril—type 2 diabetes mellitus	0.000117	0.000676	CcSEcCtD
Halofantrine—Nausea—Losartan—type 2 diabetes mellitus	0.000115	0.000662	CcSEcCtD
Halofantrine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000113	0.000654	CcSEcCtD
Halofantrine—Dizziness—Ramipril—type 2 diabetes mellitus	0.00011	0.000632	CcSEcCtD
Halofantrine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000105	0.000608	CcSEcCtD
Halofantrine—Rash—Ramipril—type 2 diabetes mellitus	0.000104	0.000603	CcSEcCtD
Halofantrine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000104	0.000602	CcSEcCtD
Halofantrine—Headache—Ramipril—type 2 diabetes mellitus	0.000104	0.000599	CcSEcCtD
Halofantrine—Nausea—Ramipril—type 2 diabetes mellitus	9.84e-05	0.000568	CcSEcCtD
Halofantrine—CYP2D6—Metabolism—CBS—type 2 diabetes mellitus	1.4e-05	0.000333	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—HK1—type 2 diabetes mellitus	1.39e-05	0.000332	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.39e-05	0.000332	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.39e-05	0.000332	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.39e-05	0.000332	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GLP1R—type 2 diabetes mellitus	1.38e-05	0.00033	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—KCNJ11—type 2 diabetes mellitus	1.34e-05	0.000321	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GCKR—type 2 diabetes mellitus	1.34e-05	0.000321	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—HSD3B2—type 2 diabetes mellitus	1.34e-05	0.000321	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—LPA—type 2 diabetes mellitus	1.34e-05	0.000321	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—COX2—type 2 diabetes mellitus	1.34e-05	0.000321	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—SLC5A2—type 2 diabetes mellitus	1.34e-05	0.000321	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—NCOA6—type 2 diabetes mellitus	1.32e-05	0.000315	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.32e-05	0.000315	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.32e-05	0.000315	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—UCP3—type 2 diabetes mellitus	1.3e-05	0.00031	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—UCP2—type 2 diabetes mellitus	1.3e-05	0.00031	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—HSD11B1—type 2 diabetes mellitus	1.3e-05	0.00031	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.29e-05	0.000309	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—SLC2A2—type 2 diabetes mellitus	1.29e-05	0.000308	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ALDOB—type 2 diabetes mellitus	1.29e-05	0.000308	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CPT1A—type 2 diabetes mellitus	1.27e-05	0.000302	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—MTR—type 2 diabetes mellitus	1.27e-05	0.000302	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.26e-05	0.0003	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.25e-05	0.000299	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—NAMPT—type 2 diabetes mellitus	1.24e-05	0.000296	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—HBA1—type 2 diabetes mellitus	1.23e-05	0.000294	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—LIPC—type 2 diabetes mellitus	1.23e-05	0.000294	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GCK—type 2 diabetes mellitus	1.23e-05	0.000294	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.23e-05	0.000293	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CYP11A1—type 2 diabetes mellitus	1.23e-05	0.000293	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	1.22e-05	0.000291	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.21e-05	0.00029	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—SLC9A1—type 2 diabetes mellitus	1.2e-05	0.000287	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GLP1R—type 2 diabetes mellitus	1.2e-05	0.000286	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CETP—type 2 diabetes mellitus	1.19e-05	0.000284	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.16e-05	0.000277	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.16e-05	0.000277	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	1.14e-05	0.000273	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.12e-05	0.000267	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.12e-05	0.000267	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.12e-05	0.000267	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.12e-05	0.000267	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.12e-05	0.000267	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—SLC2A2—type 2 diabetes mellitus	1.12e-05	0.000267	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PSMD6—type 2 diabetes mellitus	1.11e-05	0.000264	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—SREBF1—type 2 diabetes mellitus	1.11e-05	0.000264	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—SNAP25—type 2 diabetes mellitus	1.11e-05	0.000264	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	1.1e-05	0.000264	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	1.1e-05	0.000264	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	1.1e-05	0.000264	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	1.1e-05	0.000264	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CPT1A—type 2 diabetes mellitus	1.1e-05	0.000262	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—MTR—type 2 diabetes mellitus	1.1e-05	0.000262	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CTGF—type 2 diabetes mellitus	1.09e-05	0.000259	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.08e-05	0.000259	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—HMGCR—type 2 diabetes mellitus	1.08e-05	0.000257	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—NAMPT—type 2 diabetes mellitus	1.08e-05	0.000257	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.07e-05	0.000255	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GCK—type 2 diabetes mellitus	1.07e-05	0.000255	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—LIPC—type 2 diabetes mellitus	1.07e-05	0.000255	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—HBA1—type 2 diabetes mellitus	1.07e-05	0.000255	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CYP11A1—type 2 diabetes mellitus	1.06e-05	0.000254	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	1.06e-05	0.000253	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ADRA2A—type 2 diabetes mellitus	1.05e-05	0.000251	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—SLC9A1—type 2 diabetes mellitus	1.04e-05	0.000249	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CETP—type 2 diabetes mellitus	1.03e-05	0.000246	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.02e-05	0.000245	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.02e-05	0.000245	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CYP2E1—type 2 diabetes mellitus	1.01e-05	0.000242	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—SLC2A1—type 2 diabetes mellitus	1e-05	0.000239	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CYP1A2—type 2 diabetes mellitus	1e-05	0.000239	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	9.98e-06	0.000238	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	9.84e-06	0.000235	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CYP3A4—type 2 diabetes mellitus	9.76e-06	0.000233	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	9.61e-06	0.000229	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GCG—type 2 diabetes mellitus	9.59e-06	0.000229	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—SLC2A4—type 2 diabetes mellitus	9.59e-06	0.000229	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PSMD6—type 2 diabetes mellitus	9.58e-06	0.000229	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—SNAP25—type 2 diabetes mellitus	9.58e-06	0.000229	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—SREBF1—type 2 diabetes mellitus	9.58e-06	0.000229	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	9.52e-06	0.000227	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	9.52e-06	0.000227	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	9.52e-06	0.000227	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CTGF—type 2 diabetes mellitus	9.41e-06	0.000225	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—HMGCR—type 2 diabetes mellitus	9.32e-06	0.000223	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	9.19e-06	0.000219	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	9.19e-06	0.000219	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	9.13e-06	0.000218	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	9.13e-06	0.000218	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ADRA2A—type 2 diabetes mellitus	9.12e-06	0.000218	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	9e-06	0.000215	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	9e-06	0.000215	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	8.83e-06	0.000211	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	8.79e-06	0.00021	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	8.79e-06	0.00021	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	8.77e-06	0.000209	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	8.77e-06	0.000209	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	8.77e-06	0.000209	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	8.76e-06	0.000209	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	8.72e-06	0.000208	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	8.67e-06	0.000207	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	8.67e-06	0.000207	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	8.64e-06	0.000206	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	8.56e-06	0.000204	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	8.49e-06	0.000203	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	8.49e-06	0.000203	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	8.49e-06	0.000203	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	8.46e-06	0.000202	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	8.45e-06	0.000202	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	8.41e-06	0.000201	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	8.31e-06	0.000198	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	8.31e-06	0.000198	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.27e-06	0.000197	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	8.27e-06	0.000197	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	8.23e-06	0.000196	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	8.12e-06	0.000194	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	7.98e-06	0.000191	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	7.88e-06	0.000188	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	7.87e-06	0.000188	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	7.87e-06	0.000188	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	7.87e-06	0.000188	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	7.72e-06	0.000184	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	7.67e-06	0.000183	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	7.65e-06	0.000183	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	7.53e-06	0.00018	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	7.49e-06	0.000179	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	7.47e-06	0.000178	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	7.37e-06	0.000176	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	7.34e-06	0.000175	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	7.22e-06	0.000172	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	7.22e-06	0.000172	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	7.22e-06	0.000172	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	7.22e-06	0.000172	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	7.2e-06	0.000172	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	7.16e-06	0.000171	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.16e-06	0.000171	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	7.15e-06	0.000171	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	7.13e-06	0.00017	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	7.11e-06	0.00017	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	7.11e-06	0.00017	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	7.06e-06	0.000169	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	7.03e-06	0.000168	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	6.94e-06	0.000166	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	6.92e-06	0.000165	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	6.83e-06	0.000163	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	6.82e-06	0.000163	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	6.82e-06	0.000163	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	6.78e-06	0.000162	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	6.65e-06	0.000159	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	6.64e-06	0.000159	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	6.52e-06	0.000156	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	6.44e-06	0.000154	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	6.43e-06	0.000154	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	6.38e-06	0.000152	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	6.36e-06	0.000152	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	6.33e-06	0.000151	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	6.31e-06	0.000151	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	6.24e-06	0.000149	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	6.19e-06	0.000148	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	6.12e-06	0.000146	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	6.01e-06	0.000143	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	5.88e-06	0.00014	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	5.88e-06	0.00014	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	5.88e-06	0.00014	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.88e-06	0.00014	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	5.87e-06	0.00014	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	5.85e-06	0.00014	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	5.77e-06	0.000138	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	5.77e-06	0.000138	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	5.76e-06	0.000137	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	5.73e-06	0.000137	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	5.73e-06	0.000137	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	5.73e-06	0.000137	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	5.7e-06	0.000136	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	5.61e-06	0.000134	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	5.6e-06	0.000134	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	5.58e-06	0.000133	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	5.53e-06	0.000132	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	5.5e-06	0.000131	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	5.48e-06	0.000131	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	5.46e-06	0.00013	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	5.45e-06	0.00013	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	5.4e-06	0.000129	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	5.39e-06	0.000129	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	5.35e-06	0.000128	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	5.24e-06	0.000125	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	5.22e-06	0.000125	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	5.14e-06	0.000123	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	5.14e-06	0.000123	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	5.14e-06	0.000123	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	5.09e-06	0.000121	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	5.05e-06	0.000121	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	5.02e-06	0.00012	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	5e-06	0.000119	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	4.94e-06	0.000118	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	4.9e-06	0.000117	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	4.82e-06	0.000115	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	4.76e-06	0.000114	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	4.73e-06	0.000113	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	4.73e-06	0.000113	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	4.73e-06	0.000113	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	4.7e-06	0.000112	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	4.67e-06	0.000111	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	4.65e-06	0.000111	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	4.65e-06	0.000111	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	4.58e-06	0.000109	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	4.5e-06	0.000107	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	4.49e-06	0.000107	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.46e-06	0.000106	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.46e-06	0.000106	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	4.44e-06	0.000106	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	4.32e-06	0.000103	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	4.28e-06	0.000102	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	4.09e-06	9.78e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	4.09e-06	9.78e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	3.91e-06	9.33e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.84e-06	9.18e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.84e-06	9.18e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	3.83e-06	9.15e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.83e-06	9.14e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.78e-06	9.01e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	3.74e-06	8.94e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.66e-06	8.75e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.57e-06	8.51e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	3.51e-06	8.39e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.5e-06	8.36e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.43e-06	8.18e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.41e-06	8.15e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	3.36e-06	8.02e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.36e-06	8.02e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.32e-06	7.94e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.28e-06	7.84e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.15e-06	7.52e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.09e-06	7.38e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	3.07e-06	7.34e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.99e-06	7.15e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.94e-06	7.03e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.93e-06	7e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.9e-06	6.92e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.55e-06	6.1e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.51e-06	5.98e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.3e-06	5.49e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.2e-06	5.25e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.2e-06	5.25e-05	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	2.17e-06	5.19e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.01e-06	4.8e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.88e-06	4.49e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.55e-06	3.69e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.01e-06	2.41e-05	CbGpPWpGaD
